AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$158.75
+1.91 (+1.22%)
Performance
1D
—
1W
—
1M
—
3M
+4.41%
6M
+35.96%
1Y
+31.90%
YTD
-11.16%
Open$155.90
Previous Close$156.84
Day High$158.97
Day Low$152.28
52W High$191.50
52W Low$86.99
Volume—
Avg Volume476.2K
Market Cap9.39B
P/E Ratio—
EPS$-4.66
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$171.07
Below
SMA 200
$131.37
Above
RSI (14)
51.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-58.4% upside
Current
$158.75
$158.75
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 413.75M | 1.74B | 1.62B |
| Net Income | -308,109,960 | 523.27M | 458.37M |
| Profit Margin | -74.5% | 30.1% | 28.3% |
| EBITDA | -294,113,840 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | — | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |